// App-Quantinova.ai

TCT-450 : Bare Metal Stent, Durable Polymer Drug Eluting Stent, or Biodegradable Polymer Drug Eluting Stent in Patients with Diabetes Mellitus - A Mixed Treatment Comparison Analysis of 63,940 Patient-Years of Follow-up from Randomized Trials

Researchers

Presenter

  • Bora Toklu

Principal Investigators

  • Sripal Bangalore

  • Upendra Kaul

  • Michael Attubato

  • Frederick Feit

  • Deepak Bhatt

Medical Centers

  • CUMC, New York, New York, United States

  • Gastroenterology, Mount Sinai hospital, New york, New York, United States

  • New York University School of Medicine, New York, New York, United States

  • New York University School of Medicine, New York, New York, United States

  • Fortis Escorts Hospital, New Delhi, India

  • Brigham and Womens Hospital, Brookline, Massachusetts, United States

Locations

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim